Chu Q - Search Results

1

Genome-Wide Splicing Quantitative Expression Locus Analysis Identifies Causal Risk Variants for Non-Small Cell Lung Cancer.

Jin M, Liu B, Chen C, Huang Y, Zhang H, Chen B, Song G, Zhao D, Duan L, Liu W, Yang H, Yue F, Liu P, Yuan X, Chu Q, Tian J, Hu K. Jin M, et al. Among authors: chu q. Cancer Res. 2023 May 15;83(10):1742-1756. doi: 10.1158/0008-5472.CAN-22-3184. Cancer Res. 2023. PMID: 36939399

2

Molecular and clinical analysis of Chinese patients with anaplastic lymphoma kinase (ALK)-rearranged non-small cell lung cancer.

Zhou X, Shou J, Sheng J, Xu C, Ren S, Cai X, Chu Q, Wang W, Zhen Q, Zhou Y, Li W, Pan H, Li H, Sun T, Cheng H, Wang H, Lou F, Rao C, Cao S, Pan H, Fang Y. Zhou X, et al. Among authors: chu q. Cancer Sci. 2019 Oct;110(10):3382-3390. doi: 10.1111/cas.14177. Epub 2019 Sep 23. Cancer Sci. 2019. PMID: 31444835 Free PMC article.

3

Improving tumor hypoxia and radiotherapy resistance via in situ nitric oxide release strategy.

Tu J, Tu K, Xu H, Wang L, Yuan X, Qin X, Kong L, Chu Q, Zhang Z. Tu J, et al. Among authors: chu q. Eur J Pharm Biopharm. 2020 May;150:96-107. doi: 10.1016/j.ejpb.2020.03.003. Epub 2020 Mar 6. Eur J Pharm Biopharm. 2020. PMID: 32151726

4

NRF2-Driven KEAP1 Transcription in Human Lung Cancer.

Tian Y, Liu Q, Yu S, Chu Q, Chen Y, Wu K, Wang L. Tian Y, et al. Among authors: chu q. Mol Cancer Res. 2020 Oct;18(10):1465-1476. doi: 10.1158/1541-7786.MCR-20-0108. Epub 2020 Jun 22. Mol Cancer Res. 2020. PMID: 32571982

5

Clinical outcomes of coronavirus disease 2019 (COVID-19) in cancer patients with prior exposure to immune checkpoint inhibitors.

Wu Q, Chu Q, Zhang H, Yang B, He X, Zhong Y, Yuan X, Chua MLK, Xie C. Wu Q, et al. Among authors: chu q. Cancer Commun (Lond). 2020 Aug;40(8):374-379. doi: 10.1002/cac2.12077. Epub 2020 Jul 15. Cancer Commun (Lond). 2020. PMID: 32666636 Free PMC article. No abstract available.

6

Repurposed Tocilizumab in Patients with Severe COVID-19.

Tian J, Zhang M, Jin M, Zhang F, Chu Q, Wang X, Chen C, Yue H, Zhang L, Du R, Zhao D, Zeng Z, Zhao Y, Liu K, Wang M, Hu K, Miao X, Zhang H. Tian J, et al. Among authors: chu q. J Immunol. 2021 Feb 1;206(3):599-606. doi: 10.4049/jimmunol.2000981. Epub 2020 Dec 9. J Immunol. 2021. PMID: 33298617 Free PMC article.

7

Prognostic significance of KRT19 in Lung Squamous Cancer.

Yuan X, Yi M, Dong B, Chu Q, Wu K. Yuan X, et al. Among authors: chu q. J Cancer. 2021 Jan 1;12(4):1240-1248. doi: 10.7150/jca.51179. eCollection 2021. J Cancer. 2021. PMID: 33442422 Free PMC article.

8

Salvage surgery following downstaging of advanced non-small cell lung cancer by targeted therapy.

Li K, Cao X, Ai B, Xiao H, Huang Q, Zhang Z, Chu Q, Zhang L, Dai X, Liao Y. Li K, et al. Among authors: chu q. Thorac Cancer. 2021 Aug;12(15):2161-2169. doi: 10.1111/1759-7714.14044. Epub 2021 Jun 15. Thorac Cancer. 2021. PMID: 34128318 Free PMC article.

9

SIX1 Predicts Poor Prognosis and Facilitates the Progression of Non-small Lung Cancer via Activating the Notch Signaling Pathway.

Huang S, Lin W, Wang L, Gao Y, Yuan X, Zhang P, Chen Y, Chu Q. Huang S, et al. Among authors: chu q. J Cancer. 2022 Jan 1;13(2):527-540. doi: 10.7150/jca.61385. eCollection 2022. J Cancer. 2022. PMID: 35069900 Free PMC article.

10

Risk factors for immune checkpoint inhibitor-related pneumonitis in non-small cell lung cancer.

Chao Y, Zhou J, Hsu S, Ding N, Li J, Zhang Y, Xu X, Tang X, Wei T, Zhu Z, Chu Q, Neal JW, Wu JT, Song Y, Hu J. Chao Y, et al. Among authors: chu q. Transl Lung Cancer Res. 2022 Feb;11(2):295-306. doi: 10.21037/tlcr-22-72. Transl Lung Cancer Res. 2022. PMID: 35280322 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,508 results

Search Page

Filters